While the potential cost of authorizing Medicare coverage of anti-obesity drugs has presented a barrier to enacting legislation to lift the prohibition, covering these drugs under Medicare for authorized uses has already catapulted these drugs to rank among the top-selling drugs covered by Part D, Medicares outpatient drug benefit program
Neuroprotective effects of GLP-1 receptor agonists in neurodegenerative disorders: a large-scale propensity-matched cohort study
Back Kolata, G (23 Sept 1997) 'How Fen-Phen, 'a diet miracle,' rose and fell, The New York Times
In each case, users complained that the drug had given some part of their bodies a surprising and unfortunate flabby appearance
GLP-1 receptors are present in many tissues ranging from the brain to the heart to the retinal pigment epithelium
Notably, discontinuation is associated with weight regain and partial or complete reversal of improvements in cardiometabolic risk factors, including inflammatory markers, blood pressure, lipid profile, and blood glucose levels